id,group_id,source,exact,prefix,suffix,anno_type,position_type,start,end,tags,all,origin_tags,comment,user,title,created
zkU3CtYlEemJyF_22zNQ-A,3NabqAPM,https://europepmc.org/articles/PMC4452330/,adenocarcinoma,subsequent pathology revealing “,.” Due to the fact that most ade,TextQuoteSelector,TextPositionSelector,15950,15964,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:55:47.239183+00:00
zODnkNYiEemPOtuwNRgNTw,3NabqAPM,https://europepmc.org/articles/PMC4452330/,malignancy,helium. While being an uncommon , with an annual incidence in the,TextQuoteSelector,TextPositionSelector,7156,7166,WT_DS,yes,[WT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:34:16.405788+00:00
zC2FONYnEem2SkufZ9xP5w,3NabqAPM,https://europepmc.org/articles/PMC4452330/,insulin-like growth factor binding protein 5,"s such as CYFRA21-1, claudin-4, "," (IGFBP-5), and biglycan exist; ",TextQuoteSelector,TextPositionSelector,18091,18135,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:10:02.645108+00:00
yR-WCtYjEemkgVNtO0hVXQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Clonorchis sinensis,"factorsCongenital risk factors 
"," 
 Caroli's disease 
Opisthorchi",TextQuoteSelector,TextPositionSelector,12010,12029,MIS_OG,no,MIS_OG,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:41:19.422588+00:00
xEdh6tYnEemnw3-3QiDXSQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/, CYFRA21-1,ore specific serum marks such as,", claudin-4, insulin-like growth",TextQuoteSelector,TextPositionSelector,18068,18078,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:09:49.291546+00:00
xDvsjtYiEemJY-_GjJgXDA,3NabqAPM,https://europepmc.org/articles/PMC4452330/, malignant transformation,the bile ducts which arises from, of bile duct epithelium. While ,TextQuoteSelector,TextPositionSelector,7081,7106,WT_DS,yes,[WT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:34:01.813086+00:00
x2IG6NYlEemU7KPsPdBFrA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,metastatic disease,om hepatocellular carcinoma and ,. While there is a theoretical r,TextQuoteSelector,TextPositionSelector,15599,15617,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:55:35.451165+00:00
wBN-btYjEemJZbMNyLAAAQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/,NAFLD,ake Biliary-enteric anastomosis ,Parasitic risk factorsCongenital,TextQuoteSelector,TextPositionSelector,11958,11963,MIS_DS,yes,[MIS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:41:04.364039+00:00
vgvjtNYnEemxDyMy1yBJlg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,claudin-4," serum marks such as CYFRA21-1, ",", insulin-like growth factor bin",TextQuoteSelector,TextPositionSelector,18080,18089,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:09:38.911523+00:00
vLK2SNYlEembj8dPJF7jXA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,cholangiocarcinomas ,ration (EUS-FNA) to distinguish ,from hepatocellular carcinoma an,TextQuoteSelector,TextPositionSelector,15545,15565,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:55:17.530116+00:00
uLx0UNYiEemxzE8QCAJr5w,3NabqAPM,https://europepmc.org/articles/PMC4452330/,cancer of the bile ducts,inoma is a highly fatal primary , which arises from malignant tra,TextQuoteSelector,TextPositionSelector,7039,7063,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:33:42.393294+00:00
tpsdrNYnEemVKIOxy8RNnw,3NabqAPM,https://europepmc.org/articles/PMC4452330/,acute cholangitis,ed that biliary obstruction and , may also cause an increase in C,TextQuoteSelector,TextPositionSelector,17889,17906,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:09:26.312946+00:00
spikfNYiEemjdevye4YfOA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Cholangiocarcinoma,r articles in PMC.Go to:Abstract, is a highly fatal primary cance,TextQuoteSelector,TextPositionSelector,6994,7012,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:33:32.098680+00:00
speqvNYoEem-A6eJJd7-Bg,3NabqAPM,https://europepmc.org/articles/PMC4452330/, biliary tract cancer , trial in patients with advanced,that compared single agent gemci,TextQuoteSelector,TextPositionSelector,33986,34008,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:16:29.066916+00:00
scbSKtYjEemnuaMS2Yy_lA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Type II diabetes,sis  Age > 65 Biliary cirrhosis , Inflammatory bowel disease Exce,TextQuoteSelector,TextPositionSelector,11861,11877,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:40:40.148702+00:00
rkNI7tYpEemkjVt-7ZqwEQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/,regional lymph node metastasis,"umors, symptomatic disease, and ", all to be associated with a wor,TextQuoteSelector,TextPositionSelector,20941,20971,MIS_DS,yes,[MIS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:23:31.104581+00:00
rhvFmNYqEemdEms-3zAG3g,3NabqAPM,https://europepmc.org/articles/PMC4452330/,tumor,sessedT0 No evidence of primary ,Tis Carcinoma in situ (intraduct,TextQuoteSelector,TextPositionSelector,24119,24124,MIS_DS,yes,[MIS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:30:40.665558+00:00
rbQbeNYlEemFywPYcmF-5g,3NabqAPM,https://europepmc.org/articles/PMC4452330/, jaundice,"abdominal pain, night sweats, or","; however, the frequent biliary ",TextQuoteSelector,TextPositionSelector,15261,15270,WT_DS,no,[WT_DS],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:54:52.389771+00:00
rOzCWtYjEemmYNf3XbnN-w,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Inflammatory bowel disease,iary cirrhosis Type II diabetes , Excessive alcohol intake Biliar,TextQuoteSelector,TextPositionSelector,11878,11904,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:40:32.058838+00:00
qptmyNYoEemkicced8XtVQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/, biliary tract cancers,creatic (53 patients) as well as," (37 patients), 5-FU, leucovorin",TextQuoteSelector,TextPositionSelector,33277,33299,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:16:15.452077+00:00
qg8jOtYiEemzLW8ufrtRew,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Intrahepatic Cholangiocarcinoma,ciplinary Care of Patients with ,: Updates in ManagementKelly J. ,TextQuoteSelector,TextPositionSelector,5197,5228,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:33:17.812027+00:00
qbYIfNYnEemIhT-rZ2LJMg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,primary tumor,ntrathoracic or intra-abdominal , can also be helpful.In addition,TextQuoteSelector,TextPositionSelector,17055,17068,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:09:04.273413+00:00
pHdtOtYlEemwHhfHEtS38w,3NabqAPM,https://europepmc.org/articles/PMC4452330/,failure to thrive,"tomegaly, malaise, weight loss, ",", abdominal pain, night sweats, ",TextQuoteSelector,TextPositionSelector,15210,15227,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:54:37.083054+00:00
pEGblNYoEemGlXdc31lENw,3NabqAPM,https://europepmc.org/articles/PMC4452330/,malignancies,geneous nature of biliary tract ,". Historically, 5-FU was the fir",TextQuoteSelector,TextPositionSelector,33046,33058,WT_DS,no,[WT_DS],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:16:04.896284+00:00
o1cOttYpEem3Ucu2zWA49Q,3NabqAPM,https://europepmc.org/articles/PMC4452330/, intrahepatic cholangiocarcinoma,RI and pathologic correlation of,. (a) Yellow-grey intrahepatic m,TextQuoteSelector,TextPositionSelector,19148,19180,MIS_DS,yes,[MIS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:23:13.047890+00:00
o05BktYjEemJwYP6hBYsSQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Biliary cirrhosis,o use Hepatolithiasis  Age > 65 , Type II diabetes Inflammatory b,TextQuoteSelector,TextPositionSelector,11843,11860,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:40:16.110533+00:00
nyvNktYnEem37QMRwMaQQQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/,CEA,e 1). Carcinoembryonic antigen (,"), alpha-fetoprotein (AFP), and ",TextQuoteSelector,TextPositionSelector,17226,17229,CRT_GP,yes,[CRT_GP][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:08:47.032299+00:00
nkvzENYjEemGil9v1myQRA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Hepatolithiasis,erosing cholangitis Tobacco use ,  Age > 65 Biliary cirrhosis Typ,TextQuoteSelector,TextPositionSelector,11817,11832,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:40:07.654374+00:00
ndR9ENYqEemicBfS1sahWw,3NabqAPM,https://europepmc.org/articles/PMC4452330/,extrahepatic primary tumor,t [36]. A search to rule out an , should therefore usually be per,TextQuoteSelector,TextPositionSelector,16791,16817,WS_DS,no,WS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:30:12.801258+00:00
nD7nMNYoEemmZAuaGiSuSg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,lymph node metastases ,ts with solitary tumors without ,"was only 47%, while recurrence a",TextQuoteSelector,TextPositionSelector,31324,31346,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:15:51.605505+00:00
midI2tYnEemC_DuG9WOYAg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Carcinoembryonic antigen, should be assessed (Figure 1). ," (CEA), alpha-fetoprotein (AFP),",TextQuoteSelector,TextPositionSelector,17200,17224,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:08:38.503388+00:00
mPz_ftYlEemFyUN-H7KThw,3NabqAPM,https://europepmc.org/articles/PMC4452330/,HBV,he major risk factors including ,", HCV, PSC, NASH, or alcohol ind",TextQuoteSelector,TextPositionSelector,14748,14751,CRT_OG,no,CRT_OG,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:54:17.775871+00:00
mJHQTNYpEemdDofDwQ5vMw,3NabqAPM,https://europepmc.org/articles/PMC4452330/,biliary obstruction,istal ducts often presents with ,", ICC is often an incidental rad",TextQuoteSelector,TextPositionSelector,14994,15013,MIS_DS,yes,[MIS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:22:54.937041+00:00
lqrzQNYjEemC85tLZDyJ1w,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Primary sclerosing cholangitis,flammatory risk factors Obesity , Tobacco use Hepatolithiasis  Ag,TextQuoteSelector,TextPositionSelector,11774,11804,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:39:54.751208+00:00
lQPTqtYnEemGsCsYC0aDqw,3NabqAPM,https://europepmc.org/articles/PMC4452330/,alpha-fetoprotein,"Carcinoembryonic antigen (CEA), "," (AFP), and carbohydrate antigen",TextQuoteSelector,TextPositionSelector,17232,17249,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:08:29.929469+00:00
krYkJNYqEemnx8NXfbFf8w,3NabqAPM,https://europepmc.org/articles/PMC4452330/,intraductal tumor,ary tumorTis Carcinoma in situ (,)T1 Solitary tumor without vascu,TextQuoteSelector,TextPositionSelector,24147,24164,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:29:54.376427+00:00
kSZzcNYlEemxPhdAFsu78g,3NabqAPM,https://europepmc.org/articles/PMC4452330/,nonalcoholic steatohepatitis,nited States. NAFLD can lead to ," (NASH), eventual cirrhosis, and",TextQuoteSelector,TextPositionSelector,13465,13493,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:54:04.613898+00:00
kOA2utYnEemp7oPfqpougQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/,AFP,"tigen (CEA), alpha-fetoprotein (","), and carbohydrate antigen 19-9",TextQuoteSelector,TextPositionSelector,17251,17254,CRT_GP,yes,[CRT_GP][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:08:22.932505+00:00
jyfh0tYjEemxze8fzV_nSg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Obesity,actorsInflammatory risk factors , Primary sclerosing cholangitis ,TextQuoteSelector,TextPositionSelector,11766,11773,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:39:41.986399+00:00
jcilFNYpEemkjB-VvFVS9Q,3NabqAPM,https://europepmc.org/articles/PMC4452330/,extrahepatic adenocarcinomas,tatic lesions to the liver from , of the foregut [36]. A search t,TextQuoteSelector,TextPositionSelector,16717,16745,WS_DS,no,WS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:22:36.894377+00:00
iXAEmtYoEemyT_NdOkHwtg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,localized disease, that only 37% of patients with , underwent cancer directed surge,TextQuoteSelector,TextPositionSelector,26685,26702,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:15:20.161127+00:00
iSZYXNYlEem3Wj_TDcdo4w,3NabqAPM,https://europepmc.org/articles/PMC4452330/,HCV,) [23]. The association between , and ICC is not unique to the US,TextQuoteSelector,TextPositionSelector,12928,12931,CRT_OG,yes,[CRT_OG][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:53:51.112278+00:00
hp6WqNYqEemnxnMy1IXxXw,3NabqAPM,https://europepmc.org/articles/PMC4452330/,perihilar cholangiocarcinoma, The role of transplantation in , is significantly more defined; ,TextQuoteSelector,TextPositionSelector,42986,43014,WS_DS,yes,[WS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:29:34.313847+00:00
hRAjXNYpEem3ZHPgPJIcqA,3NabqAPM,https://europepmc.org/articles/PMC4452330/, ICCs,"lung, breast, and prostate [29]."," are often positive for CK7, CEA",TextQuoteSelector,TextPositionSelector,16368,16373,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:22:21.704663+00:00
gyrh_tYoEemc4csKkS53ew,3NabqAPM,https://europepmc.org/articles/PMC4452330/,liver metastases,neal carcinomatosis (11/14) and , (5/14) in a small subset of pat,TextQuoteSelector,TextPositionSelector,26059,26075,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:15:09.654194+00:00
gYjs6tYlEemboqvfGj1Kew,3NabqAPM,https://europepmc.org/articles/PMC4452330/,NASH,o nonalcoholic steatohepatitis (,"), eventual cirrhosis, and HCC [",TextQuoteSelector,TextPositionSelector,13495,13499,MIS_DS,yes,[MIS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:53:38.001885+00:00
fLE-ZtYqEemU9M8C24VxSQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/,map kinase,in cholangiocarcinoma including ," pathway, hepatocyte growth fact",TextQuoteSelector,TextPositionSelector,36405,36415,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:29:17.686454+00:00
fHNOltYoEemdC6eoKbbZ_w,3NabqAPM,https://europepmc.org/articles/PMC4452330/,peritoneal carcinomatosis, staging laparoscopy identified , (11/14) and liver metastases (5,TextQuoteSelector,TextPositionSelector,26021,26046,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:14:58.358476+00:00
fHHnStYjEemJrT8Mt-fEDQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/, tobacco,"is B infection [15, 17, 18], and", use [14] have been implicated i,TextQuoteSelector,TextPositionSelector,11073,11081,WT_OG,no,[WT_OG],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:39:10.674119+00:00
eZog_tYpEem1QLN8DvfucA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,PSA,", BRST-2, AFP, CEA, CA19-9, and ",", may help to exclude common pri",TextQuoteSelector,TextPositionSelector,16273,16276,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:22:02.669072+00:00
eDC0DNYlEemdCL-P7eYfsA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,metabolic syndrome, is associated with obesity and ,", is an increasing concern world",TextQuoteSelector,TextPositionSelector,13355,13373,MIS_DS,yes,[MIS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:53:22.622982+00:00
dV6LFtYoEem1-quQcHkoQA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,abdominal tumors,"cations, similar to other solid ",", are included with N1 disease c",TextQuoteSelector,TextPositionSelector,23714,23730,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:14:45.940757+00:00
dLD43tYjEemENTuvQ5UZlA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,hepatitis B infection,", diabetes [14, 16], cirrhosis, "," [15, 17, 18], and tobacco use [",TextQuoteSelector,TextPositionSelector,11034,11055,WS_DS,no,WS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:38:57.813280+00:00
ci-rYtYqEemJdEvxFzRSJQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/,EGF,"s, and epidermal growth factor (",") pathway, involved in cell prol",TextQuoteSelector,TextPositionSelector,35900,35903,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:29:00.136336+00:00
bnTGTNYqEem39N-N9aBH1A,3NabqAPM,https://europepmc.org/articles/PMC4452330/,epidermal growth factor,", involved in angiogenesis, and "," (EGF) pathway, involved in cell",TextQuoteSelector,TextPositionSelector,35875,35898,WS_GP,no,WS_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:28:53.454183+00:00
bCnaHNYlEembjkMsvAbllQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/,HCV infection, risk for ICC in the setting of , (hazard ratio (HR): 2.55; 95% c,TextQuoteSelector,TextPositionSelector,12812,12825,"WT_OG,DS",no,[WT_OG][DS],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:53:02.549853+00:00
axTjitYjEemEc3_xWqa3JA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,cirrhosis,"besity [15], diabetes [14, 16], ",", hepatitis B infection [15, 17,",TextQuoteSelector,TextPositionSelector,11023,11032,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:38:41.585635+00:00
a875yNYoEem3YbtXn2rGVQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/,T4,"nvasion of adjacent organs, and ",: tumors with any periductal-inf,TextQuoteSelector,TextPositionSelector,23590,23592,WT_OG,yes,[WT_OG][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:14:30.184894+00:00
a1GIjtYpEemEfYedSNvYag,3NabqAPM,https://europepmc.org/articles/PMC4452330/,alcohol induced cirrhosis,"cluding HBV, HCV, PSC, NASH, or "," [29]. As such, it is likely tha",TextQuoteSelector,TextPositionSelector,14772,14797,WS_DS,no,WS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:21:39.067036+00:00
ZTeNeNYjEemROn-Z4zRBTA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,diabetes,"ver disease [14], obesity [15], "," [14, 16], cirrhosis, hepatitis ",TextQuoteSelector,TextPositionSelector,11004,11012,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:38:31.577346+00:00
ZMXx4NYoEemIRd_L-Kqanw,3NabqAPM,https://europepmc.org/articles/PMC4452330/, tumors,cation is based on the number of,", vascular invasion, and direct ",TextQuoteSelector,TextPositionSelector,23237,23244,WS_DS,no,WS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:14:18.695709+00:00
ZAqIpNYqEemPTbPyOK7enQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/, Biliary Cancer,"C and ECC. In 2010, the Advanced",- (ABC-) 02 trial was published.,TextQuoteSelector,TextPositionSelector,33858,33873,WS_DS,no,WS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:28:36.176974+00:00
YwcMINYlEemLOpPDDBrhRA,3NabqAPM,https://europepmc.org/articles/PMC4452330/, hepatitis C virus infection, by Shaib et al. that noted that, was significantly more prevalen,TextQuoteSelector,TextPositionSelector,12596,12624,"WT_OG,DS",no,[WT_OG][DS],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:52:47.177466+00:00
YtvdxtYpEem3UP_b56-rKw,3NabqAPM,https://europepmc.org/articles/PMC4452330/,PSC,"isk factors including HBV, HCV, ",", NASH, or alcohol induced cirrh",TextQuoteSelector,TextPositionSelector,14758,14761,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:21:24.891831+00:00
Xfd8HNYjEemRMxcw5G9H7w,3NabqAPM,https://europepmc.org/articles/PMC4452330/,obesity,"s alcoholic liver disease [14], "," [15], diabetes [14, 16], cirrho",TextQuoteSelector,TextPositionSelector,10990,10997,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:38:19.559097+00:00
XGtIQNYqEem1Q9umJ2kBlA,3NabqAPM,https://europepmc.org/articles/PMC4452330/, solitary tumors,ation is defined as follows: T1:," without vascular invasion, T2: ",TextQuoteSelector,TextPositionSelector,23361,23377,WS_DS,yes,[WS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:28:23.592842+00:00
WZnmyNYoEemlnZ8pIMKP-A,3NabqAPM,https://europepmc.org/articles/PMC4452330/,multiple tumors," presence of vascular invasion, ",", symptomatic disease, and regio",TextQuoteSelector,TextPositionSelector,20899,20914,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:13:59.341346+00:00
WB5hGtYpEemx1lMMfCSrfQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Cholangiocarcinoma,f all gastrointestinal cancers. , can be classified into intrahep,TextQuoteSelector,TextPositionSelector,7339,7357,MIS_DS,yes,[MIS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:21:06.758116+00:00
VcJkgNYjEemPPJd_h3APow,3NabqAPM,https://europepmc.org/articles/PMC4452330/,alcoholic liver disease ,ellular carcinoma (HCC) such as ,"[14], obesity [15], diabetes [14",TextQuoteSelector,TextPositionSelector,10960,10984,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:38:06.000776+00:00
UaEHQtYqEemkkBfYGEsRqQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/, lymph node metastasis, and 74 (30%) were found to have, [60]. N1 disease had an adverse,TextQuoteSelector,TextPositionSelector,29423,29445,MIS_DS,yes,[MIS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:28:05.311297+00:00
TenDnNYpEemjggsq1wcNaQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/,ICC,e classified into intrahepatic (,) and extrahepatic (including hi,TextQuoteSelector,TextPositionSelector,7395,7398,MIS_DS,yes,[MIS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:20:49.677595+00:00
S_wrrNYoEemqLxciolTw-g,3NabqAPM,https://europepmc.org/articles/PMC4452330/,cancer,ith localized disease underwent , directed surgery [54]. While th,TextQuoteSelector,TextPositionSelector,26713,26719,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:13:37.094969+00:00
SRexkNYjEemJrFP97mvsdg,3NabqAPM,https://europepmc.org/articles/PMC4452330/, chronic pancreatitis," inflammatory bowel disease, and"," [14], as well as the historical",TextQuoteSelector,TextPositionSelector,10726,10747,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:37:44.435054+00:00
RrLMltYoEem_yAscVKmofA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Cancer,y from Memorial Sloan Kettering , Center noted that only 30% of p,TextQuoteSelector,TextPositionSelector,27383,27389,WT_DS,no,[WT_DS],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:13:28.077821+00:00
RZgvMNYpEem0CPt1AoVM7w,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Klatskin Tumors,n of hilar cholangiocarcinomas (,) on the incidence of intra- and,TextQuoteSelector,TextPositionSelector,48203,48218,WS_DS,no,WS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:20:35.386068+00:00
QcaNqNYjEemIgBcs07Dqjg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,inflammatory bowel disease,"nsis or Opisthorchis viverrini, ",", and chronic pancreatitis [14],",TextQuoteSelector,TextPositionSelector,10695,10721,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:37:32.097408+00:00
OWaqMNYoEemibDtiDI9ZpA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Cancer,CC)/International Union Against , (UICC) guidelines that were pub,TextQuoteSelector,TextPositionSelector,20440,20446,WT_DS,no,[WT_DS],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:13:05.448571+00:00
OPsYTNYjEemnuIddfKdubw,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Opisthorchis viverrini,ion with Clonorchis sinensis or ,", inflammatory bowel disease, an",TextQuoteSelector,TextPositionSelector,10671,10693,CRT_OG,no,CRT_OG,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:37:17.607942+00:00
NFxlNNYoEemkcT_SjeeFMA,3NabqAPM,https://europepmc.org/articles/PMC4452330/, Cancer, the American Joint Committee on, (AJCC)/International Union Agai,TextQuoteSelector,TextPositionSelector,20397,20404,WT_DS,no,[WT_DS],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:12:57.407417+00:00
N0ZXuNYpEemlnxvnOfXxIw,3NabqAPM,https://europepmc.org/articles/PMC4452330/, resp,"only (47% versus 20% versus 33%,",".; P = 0.03) [119]. However, thi",TextQuoteSelector,TextPositionSelector,43756,43761,WT_DS,no,[WT_DS],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:20:11.322110+00:00
MfOqpNYpEemc5KuZeEGzQA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,hilar cholangiocarcinoma, transplant for intrahepatic or ,. The 5-year tumor recurrence-fr,TextQuoteSelector,TextPositionSelector,43407,43431,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:20:02.679442+00:00
M2TAGNYjEemGp9d-xw0zvA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Clonorchis sinensis,arasitic biliary infection with ," or Opisthorchis viverrini, infl",TextQuoteSelector,TextPositionSelector,10648,10667,CRT_OG,no,CRT_OG,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:37:08.283844+00:00
LlYuOtYkEemzMGtv2rVFfA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,hepatitis C ,The association between ICC and ,has been demonstrated in the Uni,TextQuoteSelector,TextPositionSelector,12499,12511,"WT_OG,DS",yes,[WT_OG][DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:44:09.271622+00:00
KF2nxNYpEemkc4OwWqwreg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,early necrosis,nical effectiveness measured by , was seen in 90–100% of small tu,TextQuoteSelector,TextPositionSelector,42594,42608,WT_DS,no,[WT_DS],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:19:46.637714+00:00
KD-pFNYjEemtxMPpqgsnmQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/,parasitic biliary infection ,"sts, primary biliary cirrhosis, ",with Clonorchis sinensis or Opis,TextQuoteSelector,TextPositionSelector,10615,10643,WS_DS,no,WS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:36:49.244298+00:00
IY90Tu8-EemVP7cnup-2Tg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,HCC,s for hepatocellular carcinoma (,) such as alcoholic liver diseas,TextQuoteSelector,TextPositionSelector,10934,10937,MIS_DS,yes,[MIS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-10-15T11:22:53.942663+00:00
INGASNYpEem1Pzef7F79qA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,solid tumors,response evaluation criteria in ," (mRECIST), intra-arterial thera",TextQuoteSelector,TextPositionSelector,41765,41777,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:19:34.183470+00:00
IGygtNYqEemtz0cMNtMCXw,3NabqAPM,https://europepmc.org/articles/PMC4452330/,metastatic nodal disease,"f these, 32% were found to have ", [50]. A second meta-analysis fr,TextQuoteSelector,TextPositionSelector,28265,28289,"WT_GP,DS",no,[WT_GP][DS],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:26:42.209579+00:00
H4V7eNYjEemJwKevJhSF3Q,3NabqAPM,https://europepmc.org/articles/PMC4452330/,primary biliary cirrhosis,"tolithiasis, choledochal cysts, ",", parasitic biliary infection wi",TextQuoteSelector,TextPositionSelector,10588,10613,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:36:35.054166+00:00
GgwoTtYkEem17ffDpOWMVg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,nonalcoholic fatty liver disease,ased in incidence worldwide are , (NAFLD) and hepatitis C. The as,TextQuoteSelector,TextPositionSelector,12409,12441,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:43:35.220477+00:00
G_SS3NYoEemkcAfPlQQJDQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/,metastatic adenocarcinoma,"liably distinguish between ICC, ", from extrahepatic primaries or ,TextQuoteSelector,TextPositionSelector,20232,20257,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:12:16.382703+00:00
FYDBDNYmEemlmP8tzmA8Pg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,BRST-2,"K7, CK20, CDX-2, TTF-1, ER, PR, ",", AFP, CEA, CA19-9, and PSA, may",TextQuoteSelector,TextPositionSelector,16243,16249,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:57:46.259025+00:00
F9SbKtYjEem5KVdCzBr0lg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,choledochal cysts,"g cholangitis, hepatolithiasis, ",", primary biliary cirrhosis, par",TextQuoteSelector,TextPositionSelector,10569,10586,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:36:22.080672+00:00
Etd3ltYoEemGlI86PpOKSA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,tumors,ministration showed that 74% of , had hyperattenuating delayed co,TextQuoteSelector,TextPositionSelector,20091,20097,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:12:01.232779+00:00
DzsF3NYrEemGXbeOaUBqfw,3NabqAPM,https://europepmc.org/articles/PMC4452330/,nodal,studies have noted that overall ," status (N0 versus N1), as well ",TextQuoteSelector,TextPositionSelector,29136,29141,WT_GP,yes,[WT_GP][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:33:23.514544+00:00
Dc_ZuNYkEemJrmOzo9yC5A,3NabqAPM,https://europepmc.org/articles/PMC4452330/,HIV,aceptives Hepatitis C Isoniazid , Asbestos RadonOpen in a separat,TextQuoteSelector,TextPositionSelector,12302,12305,MIS_OG,no,MIS_OG,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:43:14.769870+00:00
DD4Q1tYmEemGjYPZsfTaSw,3NabqAPM,https://europepmc.org/articles/PMC4452330/,PR,"ng CK7, CK20, CDX-2, TTF-1, ER, ",", BRST-2, AFP, CEA, CA19-9, and ",TextQuoteSelector,TextPositionSelector,16239,16241,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:57:30.804384+00:00
D8SaZtYjEemjdoPFm1It7g,3NabqAPM,https://europepmc.org/articles/PMC4452330/,hepatolithiasis,"primary sclerosing cholangitis, ",", choledochal cysts, primary bil",TextQuoteSelector,TextPositionSelector,10552,10567,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:36:08.490602+00:00
ClIZqtYoEemJ06NqGjC9Nw,3NabqAPM,https://europepmc.org/articles/PMC4452330/,desmoplastic,"ation, a finding related to the ", nature of the tumor. In one stu,TextQuoteSelector,TextPositionSelector,19908,19920,WT_DS,no,[WT_DS],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:11:46.952131+00:00
Cciv-NYjEemFvBOBumzJSg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,primary sclerosing cholangitis,eral other risk factors include ,", hepatolithiasis, choledochal c",TextQuoteSelector,TextPositionSelector,10520,10550,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:35:58.433584+00:00
CPIlctYkEemEOLtstfQDsA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Hepatitis C,Hepatitis B Oral contraceptives , Isoniazid HIV Asbestos RadonOpe,TextQuoteSelector,TextPositionSelector,12280,12291,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:43:06.330442+00:00
B6H86tYmEemJsaear0dZWw,3NabqAPM,https://europepmc.org/articles/PMC4452330/, ER,"cluding CK7, CK20, CDX-2, TTF-1,",", PR, BRST-2, AFP, CEA, CA19-9, ",TextQuoteSelector,TextPositionSelector,16234,16237,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:57:23.044920+00:00
AmfRZtYkEemGqbu2DbJS2w,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Hepatitis B,otrastViral risk factors Dioxin , Oral contraceptives Hepatitis C,TextQuoteSelector,TextPositionSelector,12248,12259,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:42:55.586593+00:00
AElKKtYmEemzsT_y1gZ5Gw,3NabqAPM,https://europepmc.org/articles/PMC4452330/,TTF-1,"rs, including CK7, CK20, CDX-2, ",", ER, PR, BRST-2, AFP, CEA, CA19",TextQuoteSelector,TextPositionSelector,16228,16233,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:57:11.021142+00:00
A-ESvtYpEemp8HtU7XkHSg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,platelet derived growth factor,"tocyte growth factor, BRAF, and ", hopefully will lead to effectiv,TextQuoteSelector,TextPositionSelector,36461,36491,WS_GP,no,WS_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:18:45.416083+00:00
9mrckNYpEemtzs8-N1xQ-w,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Multiple tumors,tumor with vascular invasionT2b ,", with or without vascular invas",TextQuoteSelector,TextPositionSelector,24253,24268,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:25:32.149234+00:00
8PEhpNYiEem_YxPWH_AdOA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,primary liver cancers,yICC accounts for 10–15% of all , worldwide and is the second mos,TextQuoteSelector,TextPositionSelector,8556,8577,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:35:16.881621+00:00
82XLANYoEemIiMup_5a1Gw,3NabqAPM,https://europepmc.org/articles/PMC4452330/,hepatocyte growth factor,"a including map kinase pathway, ",", BRAF, and platelet derived gro",TextQuoteSelector,TextPositionSelector,36425,36449,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:18:17.884152+00:00
7yttCtYpEemC_he6xSKkiQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Solitary tumor,a in situ (intraductal tumor)T1 , without vascular invasionT2a So,TextQuoteSelector,TextPositionSelector,24168,24182,MIS_DS,yes,[MIS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:25:20.087203+00:00
7tKKsNYjEem5Kq-pL2ieow,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Bile duct adenomas,l hepatic fibrosis Nitrosamines , Vinyl chloride Biliary papillom,TextQuoteSelector,TextPositionSelector,12155,12173,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:42:22.840476+00:00
70ZSStYlEemiZ8Np1A2bzw,3NabqAPM,https://europepmc.org/articles/PMC4452330/,CK20,"hemical markers, including CK7, ",", CDX-2, TTF-1, ER, PR, BRST-2, ",TextQuoteSelector,TextPositionSelector,16215,16219,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:56:42.093199+00:00
6l52ztYoEem-BA99KzFYWg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,vascular endothelial growth factor,langiocarcinoma. Targets of the ," (VEGF) pathway, involved in ang",TextQuoteSelector,TextPositionSelector,35794,35828,WS_GP,no,WS_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:18:02.192168+00:00
6GxUVtYlEemJsOtma9InAw,3NabqAPM,https://europepmc.org/articles/PMC4452330/,CK7,"istochemical markers, including ",", CK20, CDX-2, TTF-1, ER, PR, BR",TextQuoteSelector,TextPositionSelector,16210,16213,CRT_GP,yes,[CRT_GP][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:56:30.889392+00:00
6AADsNYpEemRRtPGrEO0Rw,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Carcinoma in situ,No evidence of primary tumorTis , (intraductal tumor)T1 Solitary ,TextQuoteSelector,TextPositionSelector,24128,24145,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:25:08.077474+00:00
5hid2NYoEemwM8PWx-jYGg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,VEGF,ular endothelial growth factor (,") pathway, involved in angiogene",TextQuoteSelector,TextPositionSelector,35830,35834,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:17:55.614417+00:00
58fp5tYiEemGiO-5IuY1HQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/,chronic liver disease,ormal liver and with underlying , [3].Go to:2. EpidemiologyICC ac,TextQuoteSelector,TextPositionSelector,8478,8499,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:35:01.338826+00:00
4t1BFNYjEemyRyd6Cdg9Tg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Congenital hepatic fibrosis,chal cystsChemical risk factors , Nitrosamines Bile duct adenomas,TextQuoteSelector,TextPositionSelector,12114,12141,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:42:02.566127+00:00
4NulSNYlEembo-u2DFLixQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/,tumor, to elucidate the origin of the ,. Some immunohistochemical marke,TextQuoteSelector,TextPositionSelector,16159,16164,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:56:18.017783+00:00
3xY1xtYpEemPS5dmGR7YXQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Primary tumor,"tion, 2010).Primary tumor (T)TX ", cannot be assessedT0 No evidenc,TextQuoteSelector,TextPositionSelector,24061,24074,MIS_DS,yes,[MIS_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:24:53.143885+00:00
3JpHPtYoEemzO_PCsTCuXw,3NabqAPM,https://europepmc.org/articles/PMC4452330/,oncogenesis,isms and mutations critical for , in cholangiocarcinoma. Targets ,TextQuoteSelector,TextPositionSelector,35744,35755,WT_DS,no,[WT_DS],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:17:39.494965+00:00
3HqboNYjEemc2Be3aLSe9w,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Choledochal cysts,"sease 
Opisthorchis viverrini 
 ",Chemical risk factors Congenital,TextQuoteSelector,TextPositionSelector,12075,12092,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:41:51.972296+00:00
33xI_tYiEemU588kVJd37A,3NabqAPM,https://europepmc.org/articles/PMC4452330/,mouse, epithelium. Recent research in , models suggests the possibility,TextQuoteSelector,TextPositionSelector,7856,7861,CRT_OG,no,CRT_OG,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:34:47.009711+00:00
2D8vwNYnEemU8V95R8MnJw,3NabqAPM,https://europepmc.org/articles/PMC4452330/, biglycan,"binding protein 5 (IGFBP-5), and"," exist; however, none of these a",TextQuoteSelector,TextPositionSelector,18150,18159,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:10:22.674147+00:00
1mZ9ptYjEemJw8_UzOVSFg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Opisthorchis viverrini,"is sinensis 
 Caroli's disease 
"," 
 Choledochal cystsChemical ris",TextQuoteSelector,TextPositionSelector,12050,12072,MIS_OG,no,MIS_OG,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:41:41.679407+00:00
18c4ptYpEem5OD-qcahlSA,3NabqAPM,https://europepmc.org/articles/PMC4452330/, Intrahepatic Bile Duct Tumors,n Cancer (AJCC). TNM Staging for," (7th edition, 2010).Primary tum",TextQuoteSelector,TextPositionSelector,23990,24020,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:24:40.969034+00:00
162_ONYlEemJyXdO8hCawA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,adenocarcinomas,oma.” Due to the fact that most , of the liver are metastatic in ,TextQuoteSelector,TextPositionSelector,15993,16008,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:56:02.948656+00:00
11oYvNYoEemwIfPhNy6bhw,3NabqAPM,https://europepmc.org/articles/PMC4452330/,rare diseases,ing quality phase III trials in , such as cholangiocarcinoma. The,TextQuoteSelector,TextPositionSelector,35098,35111,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:17:30.887043+00:00
1-91ytYiEemJqt8RdatIeg,3NabqAPM,https://europepmc.org/articles/PMC4452330/, gastrointestinal cancers,30 years and comprises 3% of all,. Cholangiocarcinoma can be clas,TextQuoteSelector,TextPositionSelector,7312,7337,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:34:34.845997+00:00
0wVuNNYnEemblwP_80LIxg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,IGFBP-5,rowth factor binding protein 5 (,"), and biglycan exist; however, ",TextQuoteSelector,TextPositionSelector,18137,18144,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:10:14.099801+00:00
0iFnatYoEemlnjNcVBL06g,3NabqAPM,https://europepmc.org/articles/PMC4452330/,bile duct cancers,ile this study did not stratify ," by location, upon subgroup anal",TextQuoteSelector,TextPositionSelector,34649,34666,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:17:21.416711+00:00
0BFFMNYjEemPPWvj9MmiSg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Caroli's disease," factors 
Clonorchis sinensis 
 "," 
Opisthorchis viverrini 
 Chole",TextQuoteSelector,TextPositionSelector,12032,12048,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:41:30.970087+00:00
-erEztYlEem18dvisuNnsg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,CDX-2,"l markers, including CK7, CK20, ",", TTF-1, ER, PR, BRST-2, AFP, CE",TextQuoteSelector,TextPositionSelector,16221,16226,WS_GP,no,WS_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:57:00.157440+00:00
-OF00NYjEemPPssipPwEXA,3NabqAPM,https://europepmc.org/articles/PMC4452330/,Biliary papillomatosis,le duct adenomas Vinyl chloride , ThorotrastViral risk factors Di,TextQuoteSelector,TextPositionSelector,12189,12211,MIS_DS,no,MIS_DS,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:42:39.675095+00:00
-MZd4NYiEemLN8_0t1thgg,3NabqAPM,https://europepmc.org/articles/PMC4452330/,hepatocellular carcinoma, primary liver malignancy after , with a varying incidence worldw,TextQuoteSelector,TextPositionSelector,8649,8673,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T12:35:29.864094+00:00
-FXTdtYoEemLQkPxqJcliQ,3NabqAPM,https://europepmc.org/articles/PMC4452330/,BRAF,"hway, hepatocyte growth factor, ",", and platelet derived growth fa",TextQuoteSelector,TextPositionSelector,36451,36455,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-13T13:18:26.072552+00:00
